Purchase Order 75F40124P00203
Award Date 6/11/24
Potential Completion Date 6/12/25
Potential Value $152K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Calverton, MD 20705, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a direct 8(a) contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business based in Reston, Virginia, for supply chain technical support services to the Center for Drug Evaluation and Research. This labor-hour contract has a base period of 9.5 months with two 12-month option periods, carrying a total ceiling value of $4.2 million and an ultimate completion date of June 15, 2028. Work will be performed in Beltsville, Maryland. As an...
- This is a direct 8(a) sole source award of a 3-year, labor-hour (LH) type contract for program support services to the U.S. Food and Drug Administration (FDA), Office of Policy, Legislation and International Affairs (OPLIA). The contract has a ceiling value of $1,619,126.45 and was awarded to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. Aneon Brillient specializes in providing professional services to the FDA, with experience...
- This is a $164,940.82 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for database administration support for the FDA's Center for Drug Evaluation and Research (CDER). The contract is a labor-hour type with a completion date of September 25, 2026. Aneon Brillient, an SBA certified 8(a) joint venture, has extensive experience providing professional services to the FDA, including...
- This is a $326,304.48 labor-hour contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an 8(a) joint venture. The contract is for shipping, receiving, printing support, and administrative support services for the FDA's Office of Regulatory Affairs Office of Training, Education, and Development (OTED). The contract has an ultimate completion date of September 29, 2026 and was awarded on September 17, 2024 as...
- The U.S. Food and Drug Administration (FDA) awarded an 8(a) sole source contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business, for CDER science database administration support. The $485,507.74 labor-hour contract has an ultimate completion date of August 13, 2029. Aneon Brillient, LLC specializes in providing professional services to federal agencies, particularly the FDA, in areas such as medical product development, drug evaluation, and policy support. This award is...
- This is a $144,964.92 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for additive manufacturing of medical products core facility support, on a labor-hour basis. Aneon Brillient is an SBA-certified 8(a) joint venture that specializes in providing professional services to the FDA, including across the Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation...
- The Food and Drug Administration (FDA) awarded a definitive labor-hour contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture small business based in Reston, Virginia, to provide transcription services and support materials for the planning and management of Center for Drug Evaluation and Research (CDER) advisory committee meetings. The contract, valued at $642,543.27 with an ultimate completion date of February 27, 2026, was awarded as an 8(a) sole source set-aside on February...
- This is a direct 8(a) award of a 12-month, labor-hour type contract to Aneon Brillient, LLC for the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) to provide professional services support. The contract has a ceiling value of $3,266,346.36 and does not utilize a set-aside. Aneon Brillient is a minority-owned, small disadvantaged business registered as an 8(a) joint venture that specializes in providing a range of professional services to the FDA,...
- This is a 1-year, labor-hour (LH) type contract awarded to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The contract, valued at $191,129.18, is for quality management system services via a Quality Assurance Specialist III for the U.S. Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Office of Pharmaceutical Quality. The contract was awarded as a direct 8(a) sole source. Aneon Brillient, LLC...
- <p>This is a Definitive Contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, an 8(a) certified small disadvantaged business. The $2,114,246.96 Labor Hours (LH) contract is for professional services supporting the FDA's Oncology Center of Excellence. The contract has an ultimate completion date of August 11, 2025. As an 8(a) sole source award, this contract is set aside for eligible 8(a) small businesses.</p>
The Food and Drug Administration (FDA) awarded a 1-year, firm fixed price type contract to Aneon Brillient, LLC, an SBA certified 8(a) joint venture, to provide program support staff for the FDA's Office of Global Policy and Strategy. This is a direct 8(a) sole source award with a ceiling value of $152,077.08. The contract will be performed in Calverton, Maryland and has a completion date of June 12, 2025.
Generated 6/12/24, 9:51 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $152.1k | 6/11/24 |